Mr Esteves counters that principal investments, including proprietary trading and private-equity activity are only 15-20% of income, although this is still quite high by the newly chaste standards of Western firms.
And 26 pages later, Lilly counters with an ad featuring a torso with the heart exposed and attacks three rival drugs by name, including Novartis' Mellaril and Serentil, for potential heart problems.